Advocacy

Advocacy Research Treatments

Cracking the Code on Non-Small Cell Lung Cancer in Younger Adults

*December 2021* There is a growing cohort of younger adults who are being diagnosed with lung cancer under 40 years of age. Alarmingly, the research points to an increase not only in diagnosis at a young age—but particularly in women. Although the average age for a lung cancer diagnosis is…

laurabbook@gmail.comDecember 7, 2021

Advocacy Research Treatments

What Can you Expect from a Lung Cancer Clinical Trial

*November 2021* In this webinar, Dr. Mark A. Socinski, Executive Medical Director, Advent Health Cancer Institute, Orlando, FL, will explain the process of participating in a lung cancer clinical trial from beginning to end. Dr. Socinski will explain how typical lung cancer clinical trials are structured, how patients are monitored…

laurabbook@gmail.comDecember 7, 2021

Advocacy Research Treatments

Advancing Person-Centered Care Through Innovation

*November 2021* Listen to EGFR Resisters co-founder Jill Feldman's presentation at ASTRO — innovating for clinically meaningful benefits that matter to patients. The final session of the symposium was a lively debate on randomized clinical trials versus real world data. Four speakers offered points/counterpoints for randomized clinical trials versus…

laurabbook@gmail.comNovember 12, 2021

Advocacy Funding

EGFR Resisters and LCRF Research Partnership

*November 2021* RESEARCH=SURVIVAL! As you may know, we have increased our goal to $225K to keep fundraising for additional research projects that we will fund through our collaboration with LCRF in 2022. These research projects will be dedicated to EGFR+ lung cancer and hopefully lead to discoveries that will provide…

laurabbook@gmail.comNovember 12, 2021

Advocacy

Words Matter

*September 2021* EGFR Resisters co-founder Jill Feldman presented how stigmatizing words can affect patients and their families at WCLC 2021. Watch the video presentation here.

laurabbook@gmail.comNovember 11, 2021

Advocacy Research Treatments

How Oncogene-Driven Patient Groups Are Mobilizing the Global Community to Drive Research

*August 2021* It has been just over a year since we reported how oncogene-driven patient advocacy groups are disrupting the research paradigm in lung cancer.1 We have indeed come a long way since the discovery of the first EGFR mutation in lung cancer in 2004.2 ,3 Even amid the challenges of the global…

laurabbook@gmail.comNovember 10, 2021

Advocacy

The White Ribbon Project: It’s Time to Change the Lung Cancer Story

*September 2021* What is the power of the ribbon? People are using their white ribbons to start conversations within their community, in cancer centers, and with other lung cancer advocates about how we can support each other and create a sense of community. The White Ribbon Project is about taking power…

laurabbook@gmail.comNovember 10, 2021

Advocacy Funding Partners

New EGFR Resisters Multi-Year Research Partnership with Lung Cancer Research Foundation (LCRF)

*June 2021* The EGFR Resisters is thrilled to announce a new multi-year research partnership with Lung Cancer Research Foundation (LCRF)! LCRF is a large non-profit lung cancer advocacy organization based in New York whose mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment, and…

ceceJune 24, 2021

Advocacy Stories

LUNGevity’s HOPE Summit: Ivy Elkin’s Journey to Research Advocacy

*May 2021* EGFR Resister co-founder Ivy Elkins presented with Dr. Upal Basu Roy, Executive Director of LUNGevity, on “Understanding the Science of Lung Cancer and Research Advocacy” at the 2021 Hope Summit on Saturday, May 22. Her portion of the presentation centered on the importance of patient-driven research and her…

ceceJune 21, 2021

Advocacy Stories

We Honor Allen Lee, Co-Founder of EGFR Resisters

*March 2021* By Jill Feldman On behalf of The EGFR Resisters, I am heartbroken to share with you that Allen, our co-founder, passed away surrounded by his family. Please keep Allen’s family in your thoughts and prayers. Allen was an integral part of creating The EGFR Resisters. He offered diverse…

ceceJune 19, 2021

1 2 Next

Cracking the Code on Non-Small Cell Lung Cancer in Younger Adults

What Can you Expect from a Lung Cancer Clinical Trial

Advancing Person-Centered Care Through Innovation

EGFR Resisters and LCRF Research Partnership

Words Matter

How Oncogene-Driven Patient Groups Are Mobilizing the Global Community to Drive Research

The White Ribbon Project: It’s Time to Change the Lung Cancer Story

New EGFR Resisters Multi-Year Research Partnership with Lung Cancer Research Foundation (LCRF)

LUNGevity’s HOPE Summit: Ivy Elkin’s Journey to Research Advocacy

We Honor Allen Lee, Co-Founder of EGFR Resisters

GIVE TODAY

Categories

STAY CONNECTED

You Might Like

BECOME A MEMBER

QUICK LINKS

WHO WE ARE

PROJECTS

ALLIANCES & RESOURCES